Patent ID: 11905287
Assignee: THE UNIVERSITY OF BRISTOL
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  B | IPC B  C

Claim 8:
9. The process of claim 1, wherein step ii) is carried out in the presence of a ligand selected from:
tetramethyl-1,10-phenanthroline (Me4phen), di-tert-butyl-2,2′-bipyridyl (dtbpy), 2,2′-bipyridine (bpy), 1,1′-bis(diphenylphosphino)ferrocene (dppf), bis(2-di-tert-butylphosphinophenyl)ether, 1,3-bis(diphenylphosphino)propane, (dppp) 1,2-bis(diphenylphosphino)ethane (dppe), hexamethylbenzene (C6Me6), xantphos or 1,2-bis(dimethylphosphino)ethane (dmpe); and
phenanthroline (phen), dimethylphenanthroline (me2phen) tetramethyl-1,10-phenanthroline (me4phen), bathophenanthroline (bathophen), di-tert-butyl-2,2′-bipyridyl (dtbpy), 2,2′-bipyridine (bpy), dimethoxy-2,2′-bipyridyl (MeO-bpy), 1,1′-bis(diphenylphosphino)ferrocene (dppf), bis(2-di-tert-butylphosphinophenyl)ether, 1,3-bis(diphenylphosphino)propane (dppp), 1,2-bis(diphenylphosphino)ethane (dppe), hexamethylbenzene (C6Me6), neocuproine, xantphos, 1,2-is(dimethylphosphino)ethane (dmpe), or one of,